mavrilimumab Archives

Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) Begins Phase 2 Clinical Study of Vixarelimab...

Gavins Felicity - December 28, 2020 0

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...

Gavins Felicity - April 18, 2024 0

Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....

April 1, 2024

Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...

March 29, 2024

Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...

March 26, 2024

Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...

March 25, 2024

Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…

Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….

Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…

Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…

Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…

Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…

S&P 500 could move higher as per technical analysis (ARM, S&P)

Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)

Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)

BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…

Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…

Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…

Micro and Macro Tailwinds Converge for KULR

ISWH and the Rebirth of the Crypto Cycle

Tag: mavrilimumab